Background/Purpose: Escherichia coli is a common pathogen to cause clinical and subclinical mastitis in cows. A total of 57 E. coli isolates from raw milk from cows were characterized genetically and biochemically. Methods: Extended-spectrum b-lactamase (ESBL) genes, the mechanism for fluoroquinolone resistance, and variations in virulence genes and genomes of these E. coli isolates were investigated by the antimicrobial susceptibility test, simplex and multiplex polymerase chain reaction (PCR), and pulsed-field gel electrophoresis (PFGE). Results: All E. coli isolates were resistant to cloxacillin (100%) and to a lesser extent (50%) to tetracycline, neomycin, gentamycin, ampicillin, ceftriaxone, cefotaxime (CTX), and ceftazidime (CAZ). Nearly 70% of the isolates were resistant to at least two antimicrobials and 28.1% carried AmpA and AmpC genes simultaneously. The predominant bla gene was bla TEM , followed by bla CMY , bla CTX , bla SHV , and bla DHA. Among the six (10.5%) ESBL-producing E. coli carrying bla CTX-M15 , bla CTX-M55 , or bla CTX-M14 , two isolates 31 of ST410 in the ST23 complex and 58 of ST167 in the ST10 complex were also resistant to ciprofloxacin, enrofloxacin, and levofloxacin, with mutations at codon 83 from serine to leucine and codon 87 from aspartic acid to asparagine in GyrA and at codon 80 from serine to isoleucine in ParC. These isolates were genetically diverse in pulsotype analysis, lacked toxin genes of human * Corresponding author. Department of Microbiology, Immunology, and Biopharmaceutics, National Chiayi University, 300 University Road, Chiayi 60004, Taiwan, ROC.
Introduction
Mastitis in cows and goats affects milk quality, human safety, and the income of the farming industry worldwide. Cases of subclinical mastitis are much higher than those of clinical mastitis. The predominant pathogens causing mastitis are Gram-negative bacteria (25e30%), coagulasenegative Staphylococcus (20%), Staphylococcus aureus and Escherichia coli (5e10% each), Streptococcus and Enterococcus (2e5%), and other species (< 2%). 1e5 In Taiwan, the predominant pathogens causing mastitis in dairy cows are E. coli (16.8%), Staphylococcus spp. (19.2% vs. 3 .8%) pathogens. 6 As normal intestinal flora of the intestine, E. coli produces vitamins B and K and inhibits the growth of pathogens in the intestine, 7 and becomes diverse genetic groups and opportunistic pathogens to humans by incorporating different pathogenicity islands with virulence genes, for example, enterotoxigenic E. coli (ETEC) with genes for heat-stable toxin and heat-labile toxin, 8 enterohemorrhagic E. coli (EHEC) with genes for Shiga-like toxin I and II, 9 and enteropathogenic E. coli (EPEC) with genes for bundle-forming pilus. 10 The emergence of multidrug-resistant (MDR) bacteria and the transmission of these bacteria from foods to humans have become serious public health problems in treating their infection. 11, 12 b-lactamase can hydrolyze the b-lactam rings of expanded-spectrum cephalosporins (except cephamycins and carbapenems) and monobactams and then inactivates these compounds. Application of third-generation cephalosporins increases extended-spectrum b-lactamase (ESBL) Enterobacteriaceae, which are relatively high in food animals and reveal a high genetic diversity, 13, 14 indicating that farm animals are a reservoir of ESBLproducing bacteria which can infect humans. Recently, ESBL-producing E. coli has been observed in economically important animals in Europe 15, 16 and Asia, 17 in meat, fish, and raw milk, 18, 19 and in healthy dairy cattle and retail meat in the USA. 20, 21 Furthermore, fluoroquinolone-and carbapenem-resistant E. coli isolates have been reported in humans. Here, we investigated antimicrobial susceptibility, ESBL-producing genes, mutations in GyrA and ParC for fluoroquinolone resistance, and differences in virulence genes and genomes for mastitis-associated E. coli isolates.
Methods

Mastitis-associated bacterial species
A total of 412 milk samples from cows with clinical or subclinical mastitis were collected from 13 farms in Yunlin, Chiayi, and Tainan in Southern Taiwan based on the California mastitis test of microcolloid formation 22 and these samples were directly plated on Eosin Methylene Blue (EMB) agar to screen for E. coli. Bacterial colonies were further identified as E. coli by API 20E and polymerase chain reaction (PCR) amplification of the E. colispecific gene mdhR. Hemolysin types of each isolate were determined by blood agar. Informed consent was obtained from all farm owners prior to the start of this study. The use of all bacteria was supervised by the Biological Security Committee of the National Chiayi University, Chiayi, Taiwan in accordance with the laws of Taiwan. The milk samples were collected by county governors based on the guidelines of Animal Use Protocol, the Institutional Animal Care and Use Committee, National Chiayi University.
Antimicrobial susceptibility test
Antimicrobial susceptibility to ampicillin, cefepime, cefotaxime (CTX), ceftazidime (CAZ), ceftriaxone, ciprofloxacin, cloxacillin, enrofloxacin, ertapenem, gentamicin, levofloxacin, meropenem, neomycin, and tetracycline was determined by the disc diffusion method and the Clinical and Laboratory Standards Institute standard. 23 ESBL isolates were confirmed by determining their resistance to CAZ, CTX, CAZ/clavulanic acid, and CTX/ clavulanic acid. E. coli ATCC 25922 was used as the reference strain.
PCR detection of genes for b-lactamase, virulence factors, and pathogenic E. coli
The primers used to amplify five b-lactamase genes, 12 virulence genes of uropathogenic E. coli, and 10 toxin genes of other pathogenic E. coli are listed in Table 1. 24e29 Three multiplex PCR sets were developed. Multiplex PCR I was used to detect genes bla SHV , bla CTX-M3 , bla CTX-M14 , bla TEM , and bla DHA . Twelve virulence genes were amplified by multiplex PCR II for hlyA, usp, sat, fyuA, ironN, iutA, and iucD and multiplex PCR III for fimH, C for 1 minute, annealing at 60 C for 1 minute and extension at 72 C for 1 minute, and a final extension at 72 C for 10 minutes. Toxin genes for pathogenic E. coli were amplified with previously described PCR conditions. 24e29 All PCR products were separated on 2% agarose gels at 50 V for 120 minutes. After ethidium bromide staining and UV illumination, gel images were recorded and analyzed.
Sequence analysis of quinolone-resistance determining regions of gyrA, parC, and bla CTX-M The quinolone-resistance determining regions of gyrA and parC genes were amplified from two fluoroquinolone resistant strains and sensitive strains with the PCR primers listed in Table 1 . PCR products were purified and sequenced. The bla CTX-M was amplified with the primer set in Table 1 and sequenced. The sequences were compared to the NCBI database by the Blast program.
Pulsed-field gel electrophoresis analysis
The PulseNet standardized laboratory pulsed-field gel electrophoresis (PFGE) protocol for molecular subtyping of E. coli O157:H7, non-typhoidal Salmonella serotypes, and Shigella sonnei was used to analyze the isolates. 30 A total of 10 U of XbaI was used for restriction digestion. Digested DNA fragments were separated by the CHEF-DRIII system (BioRad, Hercules, CA, USA) in 1% agarose gel with 0.5X TBE running buffer at 14 C in conditions of 6 V/cm, 120 separation angle, and switching time of 4w70 seconds for 18 hours and another run for 4 hours in the same condition, with only change of voltages to 4 V/cm. PFGE images were analyzed and a unique PFGE pattern was defined as one or two DNA bands differing between PFGE patterns of two isolates.
Results
Antimicrobial susceptibility of E. coli E. coli from milk samples of the cows with clinical mastitis differed in prevalence of 13.8% (57/412) in total, 51.6% in Yunlin, 10.8% in Chiayi, and 4.1% in Tainan. Based on resistance to 1e12 antimicrobials, the number of antibiograms ranged from 13 in Yunlin to six in Chiayi and Tainan; however, the highest antimicrobial resistance was found in two isolates from Chiayi and Tainan (Table 2) . Although all 57 isolates were resistant to cloxacillin, a drug used to treat S. aureus, a total of 33.3% of the isolates were susceptible to the remaining 11 antimicrobials, with a prevalence of 64.7% in Chiayi, 37.5% in Tainan, and 15.6% in Yunlin. Prevalence of the resistance to traditional antimicrobials was 51% for tetracycline, 42% for neomycin, and 19% for gentamicin.
Regarding resistance to beta-lactam antimicrobials, 54% isolates were resistant to ampicillin of the penicillin group, while < 25% isolates were resistant to CAZ, CTX, and ceftriaxone of the third-generation cephalosporins, and one isolate was resistant to cefepime (the 4 th -generation cephalosporin). Furthermore, only six (10.7%) ESBLproducing isolates were identified and all revealed resistance to 7e11 antimicrobials (Table 2) . ESBL-producing isolates VMEC31 and VMEC58 were also resistant to fluoroquinolones (ciprofloxacin, enrofloxacin, and levofloxacin) and revealed mutations at codon 83 from serine to leucine and codon 87 from aspartic acid to asparagine in GyrA, and at codon 80 from serine to isoleucine in ParC. These isolates reduced susceptibility to carbapenems.
Variations in bla genes
Among five bla genes encoding AmpA and AmpC lactamase, the prevalent bla genes in order were bla TEM (47%), bla CMY (40%), bla CTX [bla CTX-M3-like (9%) and bla CTX-M14-like (4%)], bla SHV (9%), and bla DHA (2%) ( Table 3 ). Over 70% of the isolates contained at least one bla gene, while the number of isolates without the bla gene was identical to those resistant only to cloxacillin in Yunlin and Tainan, not Chiayi (Table 3) . The predominant bla genes were bla TEM in 43.9% (100) 31 (54) 5 (9) 13 (23) 7 (12) 1 (2) 2 (4) 2 (4) 2 (4) 11 (19) 24 (42) 29 (51) 6 (11) 5 (9) 32 (100) 17 (100) 8 (100) 57 (100) AMP Z ampicillin; CAZ Z ceftazidime; CLO Z cloxacillin; CRO Z ceftriaxone; CIP Z ciprofloxacin; CTX Z cefotaxime; ENR Z enrofloxacin; ESBL Z extended-spectrum b-lactamase; ETP Z ertapenem; FEP Z cefepime; GEN Z gentamicin; LVX Z levofloxacin; NEO Z neomycin; TET Z tetracycline.
of isolates carrying one bla gene, bla TEM and bla CMY in 17.6% of isolates with two bla genes, and bla TEM , bla CTX-M3 , and bla CMY in 10.5% of isolates with three bla genes. The latter two groups all contained AmpC bla CMY and at least one AmpA bla gene. Isolates with three bla genes were only observed in Yunlin and Tainan. In contrast to CAZ ESBL 
Differences in virulence genes
Examination of hemolysin types found a-hemolysin in 96.7% (55/57) isolates and b-and g-hemolysin in one isolate, respectively. PCR amplification of toxin genes only identified eae of EPEC in one isolate and lacked other toxin genes of EHEC, ETEC, enteroinvasive E. coli (EIEC), diffuse adherent E. coli (DAEC), and enteroaggregative E. coli (EAggEC). Among the other 13 virulence genes for urinary tract infection (UTI)-associated E. coli in humans, almost all isolates carried fimH encoding type 1 fimbriae and papGII encoding P fimbriae, and < 10% of isolates consisted of the kpsMTII encoding capsule and cnf1 and hlyA encoding cytotoxin (Table 4 ). Both capsule and cytotoxin genes were only present in the isolates from Yunlin (14%, 8/57) and Chiayi (2%, 1/57) and were absent in Tainan, while both fimbriae and cytotoxin genes were only observed in the isolates from Yunlin (7%, 4/57) and Tainan (2%, 1/57). Furthermore, siderophore genes were present in < 40% of isolates and ranged from 10.5% (6/57) for iroN, encoding the aerobactin receptor, 40.3% (23/57) for iutA and 15.8% for iucD, encoding salmochelin, and 17.5% for fyuA, encoding the yersiniabactin receptor. However, almost all isolates with iucD carried iutA.
Phylogenetic analysis
PFGE analysis separated 57 isolates into 39 pulsotypes and nontypeable ( Fig. 1 and 32 In this study, genetically diverse E. coli isolates were the predominant pathogens from the milk of cows with clinical mastitis (Fig. 1) , suggesting that these E. coli isolates may originate from the environment. Virulence factors, such as S and P fimbriae and CNF1, are important for the severity and persistence of mastitis. 33 Examining the virulence and toxin genes for disease in cattle, these E. coli isolates carried fimH, papGII, and a-hemolysin genes more prevalent than other virulence genes (> 80% vs. < 40%; Fig. 1, Table 3 ), implying that these three genes are important for clinical mastitis in cows and that these E. coli isolates was not associated with EPEC, EHEC, ETEC, EIEC, DAEC, and EAggEC pathogenic to humans.
Subtherapeutic antimicrobials are frequently used in animal feed, leading to an increase in antimicrobialresistant bacteria in the animal. In feedlot cattle, given feed with subtherapeutic antimicrobials, the isolates increased resistance to sulfamethoxazole and chloramphenicol, and did not change other antimicrobial resistance patterns. 34 Recently, MDR E. coli isolates have emerged from cows with mastitis. Antimicrobial resistance of mastitis-associated E. coli isolates differs among countries from low resistance in Sweden and higher resistance in France. 35 Additionally, E. coli isolates from the feedlot cattle were less resistant to ampicillin (5.9e24.3%), kanamycin (l5.9%), streptomycin (5.9e15.6%), tetracycline (5.9e13.5%), susceptible to cefotaxime, ceftiofur, chloramphenicol, gentamicin, and nalidixic acid, and not ESBL producers, 32, 34 while other research reported the isolates 
27 (47) 5 (9) 5 (9) 2 (4) 1 (2) 23 (40) 5 (9) However, resistance to fluoroquinolones or cephalosporins is still uncommon among coliforms isolated from bovine mastitis. Although < 50% isolates were resistant to ampicillin, gentamycin, neomycin, and tetracycline, an ESBL producer was identified in this study (Table 3) .
Beta-lactam and fluoroquinolone antimicrobials have been frequently used to treat bacterial infections in veterinary hospitals and farms. The use of a third-generation cephalosporin, ceftiofur, in dairy cows and cattle reduces the susceptibility to ceftriaxone in E. coli and does not have an effect on the maintenance and dissemination of bla CMY-2 -bearing plasmid. 37, 38 However, the application of these cephalosporins may increase ESBL-producing E. coli (Tables 4  and 5) 14,36,39,40,43e50 . The ESBL-producing isolates were more prevalent in diseased cattle than healthy cattle and were obtained from different sources. The bla CTX is the most important ESBL-related gene for ESBL-producing E. coli from cattle and its genotypes are associated with the geographic area (Tables 3 and 5 ). The prevalent genotypes of the bla CTX are bla CTX-M14 and bla CTX-M15 worldwide. However, in this study, bla CTX-M55 in the isolates from Yunlin and Tainan was the most prevalent genotype and has been reported from cattle in China. The bla CTX-M55 isolates were genetically identical from the same farm in Yunlin, implying clonal dissemination of bla CTX-M55 E. coli in Yunlin.
In the present study, we determined bla CTM-M14, bla CTM-M15 , and bla CTM-M55 responsible for ESBL in E. coli. However, bla CTM-M14 could not present simultaneously with bla CTX-M15 or bla CTM-M55 in the same isolate, indicating that bla CTM-M14 and bla CTX-M15 or bla CTM-M55 may exist mutually exclusively, possibly on different incompatibility plasmids, and therefore, the transferability of bla CTM-M14 and bla CTX-M15 or bla CTM-M55 associated elements need to be confirmed. Additionally, some MDR ESBL-producing isolates carried AmpA and AmpC bla genes simultaneously, such as bla CTX-M2 and bla CMY-2 , in hospitalized animals (Table 5) . 35 In the present study, 28.1% isolates carried AmpA and AmpC genes simultaneously (Table 3) . Carbapenem-resistant E. coli can occur in ESBL-and AmpC-producing E. coli isolates with mutations in ompF and ompC genes, 51, 52 or be through introduction of the chromosomal-and plasmid-encoded carbapenamase, to become carbapenem-resistant. 53 MDR fluoroquinolone-resistant ESBL isolates 31 and 58 with both AmpA and AmpC genes, differed in bla CTX-M genotype and pulsotypes and were located in Chiayi and Tainan, respectively. These results demonstrate different origins of these two isolates. The presence of these isolates in current cow farms and the mechanism of reduced susceptibility to carbapenem need to be further investigated. To avoid the emergence of such resistant isolates and to prevent the spreading of these isolates, the use of cephalosporins and fluoroquinolones should be limited in treating cow infection isolates, and enhanced sanitation of milk processing and transportation is needed.
In conclusion, genetically divergent E. coli isolates were less resistant to traditional antimicrobials and not related to human pathogens. Emergence of MDR fluoroquinoloneresistant ESBL producers with reduced susceptibility to carbapenem may threaten the public health.
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